Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
SUPN —
Supernus Pharmaceuticals, Inc.
CUSIP: 868459108 · Held by 3 superinvestors · Combined value: $119,323,438
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Jim Simons | 0.1% | $86,106,343 | 1,732,522 | REDUCE | -8,100 |
| 2 | Ken Griffin | 0.0% | $23,799,293 | 478,859 | REDUCE | -947,367 |
| 3 | Third Avenue Management | 1.7% | $9,417,802 | 189,493 | - | - |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | REDUCE | -8,100 | -0.5% |
| Ken Griffin | REDUCE | -947,367 | -66.4% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +85,300 | +5.2% |
| Ken Griffin | ADD | +1,239,692 | +664.6% |
Who Owns SUPN? Superinvestor Holdings
Supernus Pharmaceuticals, Inc. is held by 3 tracked superinvestors, with a combined position value of $119 million . The largest positions are held by Jim Simons (0.1% of portfolio), Ken Griffin (0.0% of portfolio), Third Avenue Management (1.7% of portfolio).
In the most recent quarter2 reduced or exited.